Description: PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
Home Page: www.purapharm.com
Wireless Centre, Phase One
Tai Po,
Hong Kong
Phone:
852 2840 1840
Officers
| Name | Title |
|---|---|
| Mr. Yu Ling Chan | Founder, Chairman & CEO |
| Ms. Yee Wai Man M.B.A., B.Sc., MBA, BBS | Exec. Director |
| Dr. Norimoto Hisayoshi Ph.D. | Chief R&D Officer and Exec. Director |
| Mr. Kwun Kiu Cheung | Financial Controller |
| Ms. Hang Woon Ma | Head of Brand & Corp. Marketing |
| Ms. Pui Hung | Group HR Director |
| Mr. Kar Fai Kwong | Head of Supply Chain |
| Ms. Charmayne Chan | Company Sec. |
| Ms. Wai Shan Li | Gen. Mang. of Clinic Segment |
| Ms. Jian Zhou | Nanning Production Director |
Exchange: HK
Country: HK
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 11.4943 |
|---|---|
| Trailing PE: | 159.4937 |
| Price-to-Book MRQ: | 1.4091 |
| Price-to-Sales TTM: | 0.8759 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 621 |